Blog

August 5, 2015May 19, 2026

Essilor Canada receives World Sight day Challenge Gold Award

Essilor Canada is proud to have been recognized with a World Sight Day Challenge GOLD AWARD for its contribution in 2014!

To celebrate World Sight Day, Essilor employees, throughout Canada, supported by management, organize awareness and fundraising events. Our company feels proud for what we’ve done to help people in the developing world also have access to vision care services. By participating in the World Sight Day Challenge, Essilor Canada and its employees have contributed towards transforming the lives of some of the over 600 million people who are blind or vision impaired simply because they do not have access to an eye examination and a pair of glasses. Our donations help to train local eyecare professionals and establish vision centers, so that Optometry Giving Sight can deliver eye care and low cost glasses in communities where these services do not currently exist.

Join us in helping to make eye care accessible for everyone by getting involved on World Sight Day, October 8, 2015!

August 4, 2015May 20, 2026

Tendo Reflects Samurai Strength and Form

Available from Lanctôt, Tendo Nomad returns with a structured look for this new men’s concept featuring strong contrasts, form and precision with a playful reference to the armor of the samurai.

The offer consists of three 100% stainless steel men’s models with geometric lines in semi-rimless topbars.

Distributed by Lanctôt: www.rlanctot.com

August 3, 2015May 20, 2026

ProDesign Adds New Shapes and Colours to Essential Collection

ProDesign Denmark has added four shapes in six colours each in the Essential Collection (models 1748-1751). By using transparent colour all the way through the lamination, ProDesign has obtained a more refined look, where the wire core becomes a precious decoration.

http://prodesigndenmark.com/

August 3, 2015April 24, 2018

University of Alberta Begins First Gene Therapy Trial for Choroideremia in Canada

The University of Alberta has recently begun the enrolling and dosing of subjects in a Phase II clinical trial for a gene therapy treatment of choroideremia, a rare inherited disorder where the capillaries of the choroid degenerate, causing blindness by around middle age.

This gene therapy, in which a viral vector carrying a working copy of the REP1 gene is introduced via sub-retinal injection, was developed by NightstaRx, a UK-based biopharmaceutical company, specializing in the development of therapies for retinal dystrophies. The current phase of this trial involves six subjects, all of them men.

Ian MacDonald, Professor of Ophthalmology and Visual Sciences at the University of Alberta and leader of the clinical research team, says, “It’s a great privilege to be able to do something very positive for people with choroideremia. People have hoped for this for a long time.”

Further Information: http://www.albertahealthservices.ca/11502.asp

July 31, 2015May 19, 2026

ZEISS DriveSafe Launching August 3, 2015

Launching August 3, 2015: A new solution from ZEISS to combat visual challenges when driving.

Most drivers are exposed to difficult driving conditions that impact their vision, such as driving in rain, snow or fog, and of course driving at night. For most, this can be a major source of stress – in fact, over two thirds of adults report difficulty driving in these challenging visual conditions.

Zeiss is very excited to announce the launch of an innovative lens solution from ZEISS: ZEISS DriveSafe – a lens and coating combo to combat these challenges. Call at 1-800-268-6489 or visit www.zeiss.ca/drivesafe to learn more. Or reach out to your local ZEISS representative.